Starpharma to launch clinical trials for HIV gel
01 August, 2003 by Melissa TrudingerStarpharma has been given the all-clear from the US FDA to begin clinical trials on their dendrimer-based microcidal gel for prevention of HIV infection.
BresaGen Q4 results show dwindling cash reserves
31 July, 2003 by Melissa TrudingerAdelaide-based company BresaGen only has enough cash to last until December, according to figures released by the company today.
Axon workstation wins R&D award
31 July, 2003 by Iain ScottASX-listed Axon Instruments has picked up an R&D 100 award for its OpusExpress 6000A electrophysiology workstation.
Australia to play role in bovine genome project
30 July, 2003 by Pete YoungA $100 million international project to sequence the bovine genome is being launched following an intensive lobbying effort in which CSIRO played a key role.
Kiwis cut lab rat rates
29 July, 2003 by Jeremy TorrA new report by New Zealand's National Animal Ethics Advisory Committee (NAEAC) indicates that NZ researchers are now less inclined to reach for the rodent than in previous years, with a 17 per cent drop in the number of animals being used for research, testing or teaching last year.
Biotron files SARS therapeutic patent
29 July, 2003 by Jeremy TorrResearchers at Biotron have filed a patent covering the blocking of specific ion channel activity formed within the E protein of the SARS virus, offering a potentially new treatment for the disease.
Medica raises $4.3m for biotech investees
29 July, 2003 by Pete YoungPooled development fund Medica Holdings has completed a fund-raising trifecta for its stable of biotech investee companies.
BIF grants supports acne therapeutic
28 July, 2003 by Jeremy TorrSydney-based DermaTech Laboratories has scored a AUD$360,000 Biotechnology Innovation Fund grant from the Commonwealth government to research the development of a bacteria-neutral acne lotion.
Polymerat cheered by new development agreements
28 July, 2003 by Pete YoungMaterials science start-up Polymerat has glimpsed light at the end of the tunnel by signing its first joint product development agreements with established biotechs.
Bayer GM canola gets green light for commercial release
25 July, 2003 by Iain ScottThe Office of the Gene Technology Regulator has given Bayer CropScience the green light to commercially release its InVigor genetically modified canola.
Antisense psoriasis cream to undergo clincial study
25 July, 2003 by Melissa TrudingerAntisense Therapeutics has announced plans to conduct a pre-Phase I proof-of-concept clinical study to confirm that its antisense psoriasis treatment ATL1101 shows activity.
GM farmer warns no case for canola -- yet
24 July, 2003 by Jeremy TorrNSW farmer Bruce Finney cultivates more than 7000 hectares of GM crops, including soy beans and maize, and fully supports the use of GM cotton. Ask him about GM canola, and he tells a different story.
Gradipore to target chiral market
24 July, 2003 by Jeremy TorrHot on the heels of a new technology-exchange deal with Texas A&M University, Gradipore is to chase the chiral separation market with a product based its membrane purification technology.
GroPep wins patent for infertility drug
22 July, 2003 by Melissa TrudingerGroPep's infertility drug program has received a boost recently with the issue of a patent covering the compound, transforming growth factor beta (TGF-beta).
Ventracor aiming for CE approval by next year
22 July, 2003 by Jeremy TorrVentracor's VentrAssist left ventricular assist device may see market approval as early as next year, according to company CEO, Michael Spooner.
